-

AIS Healthcare Supports Physicians and Patients Impacted by Hurricanes Helene and Milton

DALLAS--(BUSINESS WIRE)--In response to recent hurricanes that devastated many communities across the Southeastern United States, AIS Healthcare, a leading provider of targeted drug delivery (TDD) and infusion care solutions, is providing additional support to physicians and patients to ensure continuity of care and access to life-saving medication. The destruction of critical infrastructure and extended power outages have created acute challenges for patients who rely on timely delivery and sustained access to medication used to treat severe chronic pain and spasticity.

To address these near-term supply chain disruptions, AIS Healthcare is increasing capacity at its pharmacies in Texas and Mississippi, which were not impacted by the hurricanes. This additional production capacity is intended to meet the demand of physicians and patients who use other pharmacies and may be struggling to access their medication.

“Our thoughts are with all the communities in the Southeast that have experienced immense tragedy and destruction over the last several weeks,” said Simon Castellanos, CEO of AIS Healthcare. “We see it as our responsibility to support physicians and patients in the one area we can – ensuring continuity of care by making essential medications available. Our pharmacy teams have been working around the clock to add capacity and respond to physicians and patients who cannot wait to have their next prescription filled. I’m proud of the work we have done and believe it is absolutely crucial we take action to provide essential medication in times of crises. We are committed to doing whatever is necessary to help all physicians, patients, and our industry during this difficult time.”

AIS Healthcare is dedicated to prioritizing the health and safety of all patients in need of care during this period of recovery. To support those who are recovering from hurricanes Milton and Helene, the American Red Cross is accepting donations here.

About AIS Healthcare

As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.

Learn more at aiscaregroup.com.

Contacts

Simon Castellanos
877.443.4006

AIS Healthcare


Release Versions

Contacts

Simon Castellanos
877.443.4006

More News From AIS Healthcare

AIS Healthcare Awarded a Group Purchasing Agreement for 503A Intrathecal Compounded Medications with Premier, Inc.

DALLAS--(BUSINESS WIRE)--AIS Healthcare has been awarded a group purchasing agreement for 503A intrathecal compounded medications with Premier, Inc., effective July 1, 2025. The new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for sterile, patient-specific intrathecal pain pump medications. In addition, to assist with compliance policies, this agreement with Premier will provide member hospitals with site audit e...

AIS Healthcare Recognized with URAC Leader in Performance Measurement Award

DALLAS--(BUSINESS WIRE)--AIS Healthcare, the leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to announce that it has been named a 2024 Pioneer in URAC’s Leaders in Performance Measurement (LPM) recognition program. This is the second year in a row that AIS Healthcare has been recognized as a Pioneer by URAC for promoting trust in the quality of care delivered through performance measurement activities. To be recognized with the Pioneer in Performance Measu...

Advanced Infusion Care (AIC) now offers GC Biopharma’s ALYGLO™ [Immune Globulin Intravenous (Human-stwk) 10% liquid]

DALLAS--(BUSINESS WIRE)--AIC, a division of AIS Healthcare, now offers ALYGLO™, manufactured by GC Biopharma, for the treatment of patients with primary humoral immunodeficiency (PI) in adults. This includes, but is not limited to, the humoral immune defect in congenital agammaglobulinemia, common variable immunodeficiency (CVID), X-linked agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiency (SCID). The nationally accredited home infusion teams at AIC collaborate c...
Back to Newsroom